In the bustling world of CBD Oil UK, where pain, anxiety, and sleep are the driving forces behind medical cannabis use, gastrointestinal symptoms like nausea and upset stomach are not far behind. Research has shown that even small doses of cannabis can offer relief for these digestive issues and stimulate appetite, making it a valuable tool for those suffering from conditions like inflammatory bowel disease (IBD).
IBD, which encompasses Crohn’s disease and ulcerative colitis, can have debilitating symptoms such as diarrhea, fatigue, abdominal pain, reduced appetite, and weight loss. The endocannabinoid system, with its cannabinoid receptors scattered throughout the gastrointestinal system, plays a crucial role in maintaining balance and order. The interaction between endogenous compounds and cannabinoids derived from cannabis can support this system, providing relief for those with IBD.
Recent surveys conducted in Puerto Rico and New York and Minnesota have found that a significant percentage of IBD patients use cannabis to manage their symptoms. In Puerto Rico, where medicinal cannabis was legalized for specific conditions including Crohn’s disease, patients reported using cannabis to treat various symptoms like abdominal pain, weight loss, and diarrhea. The majority of users noted that cannabis improved their quality of life and would recommend it to others.
Similarly, patients in New York and Minnesota reported fewer IBD-related emergency room visits and reduced impacts of symptoms on their daily life after using cannabis. Studies and reviews have highlighted promising results of cannabinoid usage for IBD treatment, with many patients reporting symptom relief and an increase in overall quality of life.
While there is still a need for further research on optimal dosages and administration methods, the evidence so far underscores the potential benefits of cannabis for managing IBD symptoms. Gastroenterologists are encouraged to discuss the benefits and risks of cannabinoid use with their patients to ensure informed decisions are made.
In conclusion, the world of CBD Oil UK is showing promising results for those suffering from IBD, with cannabis emerging as a valuable tool for managing symptoms and improving quality of life. As research continues to unfold, the potential of cannabis in the treatment of inflammatory bowel disease remains an area of great interest and hope for patients and healthcare providers alike.
Sources:
– Leung, Janni et al. “Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada.” Psychopharmacology vol. 239,5 (2022): 1509-1519.
– Velez-Santiago, Alondra et al. “A Survey of Cannabis Use among Patients with Inflammatory Bowel Disease (IBD).” International journal of environmental research and public health vol. 20,6 5129. 15 Mar. 2023.
– Greywoode, Ruby et al. “Medical Cannabis Use Patterns and Adverse Effects in Inflammatory Bowel Disease.” Journal of clinical gastroenterology, 10.1097/MCG.0000000000001782. 14 Oct. 2022.
– Saidman, Jakob et al. “Inflammatory bowel disease and cannabis: key counseling strategies.” Current opinion in gastroenterology vol. 39,4 (2023): 301-307.
